Júlia Laporte-Amargós

518 total citations
12 papers, 155 citations indexed

About

Júlia Laporte-Amargós is a scholar working on Oncology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Júlia Laporte-Amargós has authored 12 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Infectious Diseases and 4 papers in Pharmacology. Recurrent topics in Júlia Laporte-Amargós's work include Neutropenia and Cancer Infections (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Júlia Laporte-Amargós is often cited by papers focused on Neutropenia and Cancer Infections (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Júlia Laporte-Amargós collaborates with scholars based in Spain, Italy and France. Júlia Laporte-Amargós's co-authors include Carlota Gudiol, Jordi Carratalà, Adaia Albasanz‐Puig, Carolina García‐Vidal, Pedro Puerta‐Alcalde, José Antonio Martínez, Eva Domingo‐Doménech, Àlex Soriano, Celia Cardozo and Francesc Marco and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Júlia Laporte-Amargós

12 papers receiving 151 citations

Peers

Júlia Laporte-Amargós
Tim Götting Germany
Gemma Martínez‐Nadal Spain
Funda Şimşek Türkiye
Nefise Öztoprak Türkiye
Olga Rodríguez-Núñez Spain
M. Tumbarello Italy
Guillermo Martín-Gutiérrez Spain
Elif Şahin Horasan Türkiye
Samia Arshad United States
Emily Welch United States
Tim Götting Germany
Júlia Laporte-Amargós
Citations per year, relative to Júlia Laporte-Amargós Júlia Laporte-Amargós (= 1×) peers Tim Götting

Countries citing papers authored by Júlia Laporte-Amargós

Since Specialization
Citations

This map shows the geographic impact of Júlia Laporte-Amargós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Júlia Laporte-Amargós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Júlia Laporte-Amargós more than expected).

Fields of papers citing papers by Júlia Laporte-Amargós

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Júlia Laporte-Amargós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Júlia Laporte-Amargós. The network helps show where Júlia Laporte-Amargós may publish in the future.

Co-authorship network of co-authors of Júlia Laporte-Amargós

This figure shows the co-authorship network connecting the top 25 collaborators of Júlia Laporte-Amargós. A scholar is included among the top collaborators of Júlia Laporte-Amargós based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Júlia Laporte-Amargós. Júlia Laporte-Amargós is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Laporte-Amargós, Júlia, Francisco Carmona-Torre, Pedro Puerta‐Alcalde, et al.. (2024). Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial. Clinical Microbiology and Infection. 31(2). 211–219. 1 indexed citations
2.
Abelenda-Alonso, Gabriela, Alba Bergas, Júlia Laporte-Amargós, et al.. (2024). An Ocean between the Waves: Trends in Antimicrobial Consumption in Hospitalized Patients with COVID-19. Antibiotics. 13(1). 55–55. 6 indexed citations
3.
Laporte-Amargós, Júlia, Aída González-Díaz, Alberto Mussetti, et al.. (2023). Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy Patient. Antimicrobial Agents and Chemotherapy. 67(11). e0027223–e0027223. 3 indexed citations
4.
Castelli, Valeria, Pedro Puerta‐Alcalde, Júlia Laporte-Amargós, et al.. (2023). The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients. Antibiotics. 12(12). 1722–1722. 2 indexed citations
5.
Laporte-Amargós, Júlia, Alba Bergas, Helena Pomares, et al.. (2023). Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients. Pathogens. 12(2). 228–228. 6 indexed citations
6.
Laporte-Amargós, Júlia, Marta Ulldemolins, Mireia Puig‐Asensio, et al.. (2023). Prolonged vs short-term infusion of β-lactam antibiotics for the treatment of febrile neutropenia: A systematic review and meta-analysis. Journal of Infection. 87(3). 190–198. 3 indexed citations
7.
Laporte-Amargós, Júlia, et al.. (2023). Mortality and sequelae of tuberculous meningitis in a high-resource setting: A cohort study, 1990–2017. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(3). 124–129. 2 indexed citations
8.
Laporte-Amargós, Júlia, et al.. (2022). Mortality and sequelae of tuberculous meningitis in a high-resource setting: A cohort study, 1990–2017. Enfermedades Infecciosas y Microbiología Clínica. 42(3). 124–129. 3 indexed citations
9.
Grillo, Sara, Guillermo Cuervo, Júlia Laporte-Amargós, et al.. (2021). Bloodstream Infection and Endocarditis Caused by Staphylococcus aureus in Patients with Cancer: A Multicenter Cohort Study. Infectious Diseases and Therapy. 11(1). 323–334. 5 indexed citations
10.
11.
Martínez‐Nadal, Gemma, Pedro Puerta‐Alcalde, Carlota Gudiol, et al.. (2019). Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance. Clinical Infectious Diseases. 70(6). 1068–1074. 101 indexed citations
12.
Gudiol, Carlota, Montserrat Arnán, Manuela Aguilar‐Guisado, et al.. (2019). A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients. Antimicrobial Agents and Chemotherapy. 64(2). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Götting Breakdown of academic impact, for papers by Gemma Martínez‐Nadal Breakdown of academic impact, for papers by Funda Şimşek Breakdown of academic impact, for papers by Nefise Öztoprak Breakdown of academic impact, for papers by Olga Rodríguez-Núñez Breakdown of academic impact, for papers by M. Tumbarello Breakdown of academic impact, for papers by Guillermo Martín-Gutiérrez Breakdown of academic impact, for papers by Elif Şahin Horasan Breakdown of academic impact, for papers by Samia Arshad Breakdown of academic impact, for papers by Emily Welch
Rankless by CCL
2026